Safety and effectiveness of corneal neurotization from the supratrochlear nerve with nerve graft

Safety and effectiveness of corneal neurotization from the supratrochlear nerve with nerve graft - Corneal neurotization

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021423

Enrollment

Registered

2016-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

trigeminal neurotrophic keratopathy

Interventions

Cable graft is placed between contralateral supratrochlear nerve and pericorneal tissue

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient with unilateral facial palsy and anesthetic corneal keratopathy

Exclusion criteria

Exclusion criteria: 1, active infection with corneal ulcer 2,severe cardiac failure, major pulmonary dysfunction 3, patients who cannot be followed or denied to be followed up 3, pregnant patients 4, patient who is attending other experimental protocol

Design outcomes

Primary

Measure	Time frame
corneal sensibility test at post op. 6 month, 12month, 24month, 36month	—

Secondary

Measure	Time frame
A Schirmer&#39;s test at post op. 6 month, 12month, 24month, 36month	—

Countries

Japan

Contacts

Public ContactYoshimichi Imai

Graduate School of Medicine Department of Plastic and Reconstructive Surgery

yo-imai@med.tohoku.ac.jp0227177748

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026